Raloxifene can benefit prostate cancer.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D020849:Raloxifene Hydrochloride